Published 12 Aug 2021 | Written By Cadence
This letter was recently published here:
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance – PubMed (nih.gov)
Keep reading
See all
Adalimumab Clearance, rather than Trough Level,May Have Greatest Relevance to Crohn’s Disease Therapeutic Outcomes Assessed Clinically and Endoscopically.
12 Aug 2021
Lower adalimumab clearance is associated with an improved clinical outcome for patients with Crohn’s disease and may be a superior pharmacokinetic measure than concentration.
